Business
NBA looks to China for growth, renewing a foothold in its second-largest market
Michael Porter Jr. #17 of the Brooklyn Nets shoots the ball during practice and media availability as part of 2025 NBA Global Games China at Venetian Arena on October 9, 2025 in Macao, China.
Ryan Stetz | National Basketball Association | Getty Images
MACAO — The National Basketball Association returns to China for the first of two Macao games on Friday, and the impact extends beyond the preseason.
The weekend marks a major milestone for the NBA, as years of rebuilding its relationship with its second-largest market culminate with the Phoenix Suns and Brooklyn Nets facing off in the Venetian Arena here. For the NBA, it could mean unlocking future growth in China as television viewership declines in the U.S.
The NBA’s return to China comes after a six-year hiatus following 2019 comments by Daryl Morey, then-Houston Rockets general manager, voicing support for Hong Kong protestors and setting off an international crisis. For the next three years, the league was largely absent from Chinese airwaves in China. Nearly every Chinese sponsor cut ties with the NBA.
But the NBA’s history in China dates back to the 1970s. Since 1979, the NBA and USA basketball have played a total of 48 games in China, according to NBA data. Demand for the 2025 Macao games, set for Friday and Sunday, was high: At the upper end, tickets were going for more than $3,000.
And there are signs of progress off the court, too.
The league on Thursday announced a renewed partnership with Alibaba, making the tech company’s cloud unit the official cloud computing and AI partner of NBA China. The partnership already included a dedicated NBA section across Alibaba platforms that allow fans in China to engage in content or shop for NBA merchandise.
Alibaba chairman Joe Tsai owns the Nets.
The NBA is hoping to tap into basketball fans among China’s 1.4 billion-person population as the league grapples with cord-cutting and changing viewership habits at home. Last season, television viewership dipped.
Meanwhile, in China, the NBA has won a massive fan base. It’s the most-followed sports league on social media, according to the league, with 425 million followers across league, team and player platforms. To put that number in perspective, that’s more than the entire population of the United States.
The league has also been investing in infrastructure in China. It now has four flagship stores, 45 NBA kids stores, seven NBA e-commerce flagship stores and more than 5,000 partner retail stores across the country.
“We’ve created a lot of fan experiences here, and the goal is to really make something special where the fans of the NBA in Asia and China can really get a true taste of what the NBA has to offer,” said Patrick Dumont, Dallas Mavericks owner and Las Vegas Sands president, who was an architect of the NBA’s return to China. Las Vegas Sands owns the Venetian in Macao, where the two preseason games will be played.
To raise awareness and give back to the local communities, the league has hosted more than 140 community outreach events and built 100 spaces for children and family to learn, live and play in China since 2004. More than 400 current and former NBA players have participated in this program.
This week, the Nets are hosting 13 youth clinics across Hong Kong and Macao, in addition to a basketball court refurbishment project in Hong Kong.
It’s not just at the league level where professional basketball is tapping into China’s potential. At least seven NBA teams and 10 individual players are working with East Goes Global, a marketing and consulting firm that bridges the western brands with Chinese audiences.
“We’re able to localize a ton of their western-facing content, creating new, unique content, even showing up to a lot of the team’s media days to shoot China specific content,” said Andrew Spalter, founder and CEO of the company.
East Goes Global, run by brothers Andrew and Matthew Spalter, also works directly with New York Knicks star Jalen Brunson to grow his international profile in China.
“Jalen is actively speaking to his Chinese audience more so than most athletes have ever done in the past. He’s trying to learn calligraphy, he’s eating Chinese foods, he’s collaborating with Chinese influencers and celebrities,” said Matthew Spalter, chief operating officer at East Goes Global.
Dumont said the Macao games are part of a multi-year deal and that executives are already thinking about next year.
“I think it’s the classic win, win, win,” he said. “It’s great for the NBA because it gets to bring its best product, top teams, real games, real experiences, and it allows local fans who maybe don’t have the ability to get to the U.S. to get to experience the NBA and see basketball played at the highest level.”
Business
FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Thomas Fuller | SOPA Images | Lightrocket | Getty Images
UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.
The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.
“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”
The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.
UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.
The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”
UniQure didn’t immediately comment.
The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.
Business
US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India
The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.
Business
PSX reclaims 160k level with 5,433-point jump | The Express Tribune
Foreign funds would divert their liquidity into buying Pakistan’s stocks. This would merely increases prices of shares and be profitable for those who already hold stocks. PHOTO: FILE
KARACHI:
The Pakistan Stock Exchange on Thursday staged a powerful rebound, when the benchmark KSE-100 index surged by over 5,400 points, reclaiming the 160,000 level in a decisive rally driven by strong institutional buying and renewed investor confidence.
The session marked a sharp recovery from recent volatility as bulls took control from the opening bell. Index-heavy stocks like Hubco (+7.15%), OGDC (+8.24%) and others led the charge, contributing significantly to the gains, while trading volumes rose to 724 million shares valuing at Rs35 billion. K-Electric dominated the volumes with over 115 million shares traded.
At the close of trading, the KSE-100 index posted a strong gain of 5,433.46 points, or 3.49%, and settled at 161,210.68.
According to Arif Habib Limited (AHL), the stock market staged a strong rebound as the benchmark index pushed higher from its 200-day moving average, gaining 3.49% to reclaim the 160,000 level. Market participation remained broadly positive, with 85 shares advancing while 14 declined among key index movers.
The major contributors included Hubco, which rose 7.15%, OGDC, higher by 8.24%, and Fauji Fertiliser, which despite declining 2.93% remained among the notable stocks influencing index movements. On the downside, Abbott Laboratories fell 3.5%, Highnoon Laboratories declined 2.42% and Fatima Fertiliser slipped 0.82%, emerging as the biggest drags on the index.
Meanwhile, geopolitical and macroeconomic developments also remained in focus. Pakistan’s top military leader stated that the country was willing to halt operations against Afghanistan if the Taliban government stopped supporting terror groups operating from its territory. On the economic front, Saudi authorities assured Pakistan of secure energy supplies through the Port of Yanbu on the Red Sea, helping support the country’s energy requirements, it said.
Additionally, Pakistan was preparing to introduce several measures, including weekly petroleum price revisions, compensation to oil companies for higher insurance costs and import premiums, and fuel conservation initiatives. Finance Minister Muhammad Aurangzeb also assured a parliamentary panel that Pakistan had adequate petroleum reserves, including 28 days of petrol and diesel supply.
Despite the strong rebound during the session, the market remained down about 4% week-on-week while heading into the final trading day and continued to trade within the large gap created by Monday’s sharp decline, AHL said.
“Bulls stormed back with authority in Thursday’s trading session, firmly planting their feet from the outset,” Topline Securities stated in its review. Strong institutional buying turned the tide after the market’s recent overreaction to regional issues, as confidence swiftly replaced caution.
Momentum gathered strength as the session progressed, driving the index to the intra-day high of 5,699 points before closing at 161,211 – up 5,433 points. It was not merely a rebound, but a statement rally marked by decisive accumulation and broad-based strength. Index-heavy constituents including Hubco, OGDC, Fauji Fertiliser, Engro Holdings and Meezan Bank led the charge, collectively contributing 2,197 points to the benchmark’s gain and reinforcing the bullish undertone, Topline said.
During the day, shares of 478 companies were traded. Of these, 350 stocks closed higher, 78 fell and 50 remained unchanged.
K-Electric was the volume leader with trading in 115.6 million shares, gaining Rs0.61 to close at Rs8.05. It was followed by Trust Securities & Brokerage (R) with 50.03 million shares, losing Rs0.04 to close at Rs0.18 and Unity Foods with 48.3 million shares, gaining Rs0.55 to close at Rs10.08. Foreign investors sold shares worth Rs1.4 billion, the National Clearing Company reported.
-
Politics1 week agoWhat are Iran’s ballistic missile capabilities?
-
Business7 days agoIndia Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Business1 week agoAttock Cement’s acquisition approved | The Express Tribune
-
Politics1 week agoUS arrests ex-Air Force pilot for ‘training’ Chinese military
-
Fashion1 week agoPolicy easing drives Argentina’s garment import surge in 2025
-
Business1 week agoHouseholds set for lower energy bills amid price cap shake-up
-
Sports6 days agoLPGA legend shares her feelings about US women’s Olympic wins: ‘Gets me really emotional’
-
Fashion7 days agoTexwin Spinning showcasing premium cotton yarn range at VIATT 2026
